168 related articles for article (PubMed ID: 24579925)
21. Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients.
Buob D; Grimbert P; Glowacki F; Labalette M; Dufossé F; Nochy D; Copin MC; Boleslawski E; Noël C; Hazzan M
Transpl Int; 2012 Jun; 25(6):663-70. PubMed ID: 22487459
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Indication Biopsies ≥5 Years After Kidney Transplant: A Single-Center Experience.
Tatar E; Simsek C; Tasli F; Cayhan VK; Karatas M; Uslu A
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):265-268. PubMed ID: 28260483
[TBL] [Abstract][Full Text] [Related]
23. Rituximab and intravenous immune globulin for desensitization during renal transplantation.
Vo AA; Lukovsky M; Toyoda M; Wang J; Reinsmoen NL; Lai CH; Peng A; Villicana R; Jordan SC
N Engl J Med; 2008 Jul; 359(3):242-51. PubMed ID: 18635429
[TBL] [Abstract][Full Text] [Related]
24. Acute transplant glomerulopathy is associated with antibody-mediated rejection and poor graft outcome.
Nair R; Fraer M; Agrawal N; Suneja M
Transplant Proc; 2010 Nov; 42(9):3507-12. PubMed ID: 21094805
[TBL] [Abstract][Full Text] [Related]
25. Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection.
Piñeiro GJ; De Sousa-Amorim E; Solé M; Ríos J; Lozano M; Cofán F; Ventura-Aguiar P; Cucchiari D; Revuelta I; Cid J; Palou E; Campistol JM; Oppenheimer F; Rovira J; Diekmann F
BMC Nephrol; 2018 Oct; 19(1):261. PubMed ID: 30309322
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
[TBL] [Abstract][Full Text] [Related]
27. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
[TBL] [Abstract][Full Text] [Related]
28. Single-dose rituximab for recurrent glomerulonephritis post-renal transplant.
Spinner ML; Bowman LJ; Horwedel TA; Delos Santos RB; Klein CL; Brennan DC
Am J Nephrol; 2015; 41(1):37-47. PubMed ID: 25634230
[TBL] [Abstract][Full Text] [Related]
29. An integrative approach for the assessment of peritubular capillaritis extent and score in low-grade microvascular inflammation-associations with transplant glomerulopathy and graft loss.
Kozakowski N; Herkner H; Eskandary F; Eder M; Winnicki W; Kläger J; Bond G; Kikic Ž
Nephrol Dial Transplant; 2019 Jan; 34(1):166-174. PubMed ID: 30053273
[TBL] [Abstract][Full Text] [Related]
30. Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab.
Mulley WR; Huang LL; Ramessur Chandran S; Longano A; Amos LAR; Polkinghorne KR; Nikolic-Paterson DJ; Kanellis J
Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28640458
[TBL] [Abstract][Full Text] [Related]
31. Glomerular fibrin thrombi in ABO and crossmatch compatible renal allograft biopsies.
Troxell ML; Norman D; Mittalhenkle A
Pathol Res Pract; 2011 Jan; 207(1):15-23. PubMed ID: 21067871
[TBL] [Abstract][Full Text] [Related]
32. Methods of analysis for peritubular capillaritis and glomerulitis in acute renal rejection: capillaritis in management of routine diagnosis.
Dos Santos DC; De Andrade LG; De Carvalho MF; Moraes Neto FA; Viero RM
Transplant Proc; 2014; 46(1):87-93. PubMed ID: 24507031
[TBL] [Abstract][Full Text] [Related]
33. Histopathologic Features that Predict Transplant Glomerulopathy Progression in a Chinese Cohort.
Li X; Chen J; Cheng D; Wang W; Xie K; Zhang M; Xu F; Wen J; Tang Z
Am J Nephrol; 2019; 49(6):425-434. PubMed ID: 30991390
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation.
Kim MG; Kim YJ; Kwon HY; Park HC; Koo TY; Jeong JC; Jeon HJ; Han M; Ahn C; Yang J
Nephrology (Carlton); 2013 Dec; 18(12):820-6. PubMed ID: 24033843
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection.
Hong YA; Kim HG; Choi SR; Sun IO; Park HS; Chung BH; Choi BS; Park CW; Kim YS; Yang CW
Transplant Proc; 2012 Jan; 44(1):182-4. PubMed ID: 22310610
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic characteristics and outcomes of late acute antibody-mediated rejection in Thai kidney transplant recipients: a single-center experience.
Larpparisuth N; Premasathian N; Vareesangthip K; Cheunsuchon B; Parichatikanon P; Vongwiwatana A
Transplant Proc; 2014; 46(2):477-80. PubMed ID: 24655993
[TBL] [Abstract][Full Text] [Related]
37. Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.
Aubert O; Higgins S; Bouatou Y; Yoo D; Raynaud M; Viglietti D; Rabant M; Hidalgo L; Glotz D; Legendre C; Delahousse M; Shah N; Sis B; Campbell P; Mengel M; Jouven X; Duong Van Huyen JP; Lefaucheur C; Loupy A
J Am Soc Nephrol; 2019 Apr; 30(4):625-639. PubMed ID: 30872323
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.
Billing H; Rieger S; Ovens J; Süsal C; Melk A; Waldherr R; Opelz G; Tönshoff B
Transplantation; 2008 Nov; 86(9):1214-21. PubMed ID: 19005402
[TBL] [Abstract][Full Text] [Related]
39. IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up.
Billing H; Rieger S; Süsal C; Waldherr R; Opelz G; Wühl E; Tönshoff B
Transpl Int; 2012 Nov; 25(11):1165-73. PubMed ID: 22897111
[TBL] [Abstract][Full Text] [Related]
40. Accompanying renal injuries did not impact graft survival in patients with transplant glomerulopathy.
Lim BJ; Joo DJ; Kim YS; Jeong HJ
Transplant Proc; 2012 Apr; 44(3):616-8. PubMed ID: 22483451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
